Tech Company Financing Transactions
Bayhill Therapeutics Funding Round
On 5/4/2005, Bayhill Therapeutics raised $35.4 million in Series B financing from De Novo Ventures, Lilly Ventures and Latterell Venture Partners.
Transaction Overview
De Novo Ventures (Lead Investor) (Fred Dotzler)
Lilly Ventures (Lead Investor) (David Thompson)
Company Information
Palo Alto, CA 94303
USA
Management Team
Browse more venture capital transactions:
Prev: 5/4/2005: Mazor Robotics venture capital transaction
Next: 5/4/2005: High Throughput Genomics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs